BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36370491)

  • 1. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease.
    Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ
    Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
    Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
    Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
    Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
    Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
    Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
    Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
    Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
    Siu MK; Wong ES; Chan HY; Ngan HY; Chan KY; Cheung AN
    Am J Pathol; 2008 Oct; 173(4):1165-72. PubMed ID: 18772339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNA signature in the progression of gestational trophoblastic disease.
    Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ
    Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
    Wong SY; Ngan HY; Chan CC; Cheung AN
    Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation.
    Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
    Carcinogenesis; 2013 Sep; 34(9):2170-7. PubMed ID: 23671128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
    Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
    Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.
    Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN
    Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression.
    Wu W; Wang Y; Xu Y; Liu Y; Wang Y; Zhang H
    Placenta; 2014 Oct; 35(10):824-30. PubMed ID: 25108485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
    Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
    Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
    Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
    Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
    Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
    Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices.
    Chan HY; Siu MK; Zhang HJ; Wong ES; Ngan HY; Chan KY; Cheung AN
    Histopathology; 2008 Aug; 53(2):139-46. PubMed ID: 18752497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of gestational trophoblastic diseases.
    Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery including fertility-sparing treatment of GTD.
    Ngu SF; Ngan HYS
    Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
    Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
    Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.